Figure 3.
Evaluation of thrombotic microangiopathies presenting in the second and third trimesters. This schema highlights recommended testing to distinguish preeclampsia with severe features/HELLP from cm-TMA or TTP. Not all possible etiologies to consider are listed in this brief schema.
*ADAMTS13 testing may also be appropriate in patients with clinical picture consistent with HELLP syndrome to rule out TTP as an alternate etiology. †Other etiologies to consider with severe renal injury are severe hypertension or catastrophic antiphospholipid syndrome.
PT/PTT, prothrombin/partial thrombplastin time.